Literature DB >> 4551303

Combination sequential chemotherapy in advanced reticulum cell sarcoma.

M Levitt, J C Marsh, R C DeConti, M S Mitchell, R T Skeel, L R Farber, J R Bertino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4551303     DOI： 10.1002/1097-0142(197203)29:3<630::aid-cncr2820290316>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  3 in total

1.  My treatment approach to patients with diffuse large B-cell lymphoma.

Authors:  James O Armitage
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Targeted therapy and hematological malignancy.

Authors:  James O Armitage
Journal:  Target Oncol       Date:  2009-02-14       Impact factor: 4.493

3.  Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.

Authors:  P W Johnson; J Whelan; S Longhurst; K Stepniewska; J Matthews; J Amess; A Norton; A Z Rohatiner; T A Lister
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.